���发背景与监管地位 — Deep Dive

By Editorial Desk · published 2026-04-12 · last reviewed 2026-05-03 · Blog

ACTH analog comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-05-03. Numbers and descriptions here follow the published literature rather than marketing material.

研发背景与监管地位

当时的短肽研究普遍关注能否穿越血脑屏障、在低剂量下产生中枢效应，Semax 属于这一路线。鼻内给药是其主要使用方式，俄语文献报道的适应症涵盖缺血性卒中、短暂性脑缺血发作、认知功能减退以及视神经病变。这些研究大多发表在当地期刊上，样本规模与终点设置同西方试验惯例存在差异，国际同行对其临床证据的强度看法不一。

各国监管态度分化明显。俄罗斯按处方药管理，部分东欧国家留有使用记录；欧盟与美国未批准其作为药物上市，市面流通品通常标注为研究用化学品。身份差异意味着标示含量、纯度与无菌性缺少统一核查。体育领域还牵涉反兴奋剂名录，跨境携带则受目的地药品法规约束。

Semax 是人工设计的七肽，序列为 Met-Glu-His-Phe-Pro-Gly-Pro，骨架取自促肾上腺皮质激素片段 ACTH(4-10)。它于二十世纪八十年代在苏联的分子遗传学研究机构内合成。设计目标是保留该片段与注意力和记忆相关的活性，同时剔除促皮质激素释放等内分泌作用。此后俄罗斯将其登记为药品并进入临床使用。

Semax Peptide Structure and Origin

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.

The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.

Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.

Semax at a glance

Semax Background And Mechanism

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.

The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.

Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.

Related pages on this site

• Comprehensive overview
• Quality dataset
• Balanced update
• Simple briefing
• Smart notes
• Quality dataset
• Reliable dataset
• Practical review

Background and Development

Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.

Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.

Semax Structure and Research Background

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its chain combines the first seven residues of corticotropin with a C-terminal proline-glycine-proline extension, a modification intended to slow enzymatic breakdown. The free peptide has a molecular mass near 813.9 daltons. It belongs to the class of ACTH-derived fragments studied for central nervous system activity rather than for adrenal steroid stimulation. This structural relationship to a natural hormone fragment is the usual starting point for describing the compound in the literature.

Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.

Reference notes

The United States House of Representatives passes a bill to curb university boycotts of Israel. OpenAI launches GPT-6, the next major version of ChatGPT. The National Fish and Wildlife Foundation announces $1.2 million in grants to reduce the extinction risk for Hawaiian forest birds and restore essential watershed habitats in Hawaii. September 4 The US military announces that it had disabled ad trackers on devices following reports that commercially available location data had been used to target its soldiers in the Middle East. The judge in the trial of Lindsay Clancy, a mother accused of murdering her three children, says he will declare a mistrial. The US Treasury announces that it has cut off Turkish investment bank Golden Global Yatirim Bankasi Anonim Sirketi and two subsidiaries from dollar transactions because of their dealings with the Iranian government. The price of diesel hits an all-time high of $5.85 per gallon, compared to an average of $3.71 a year ago and exceeding the previous high following Russia's full-scale invasion of Ukraine. September 5 The US military reports that it destroyed three IRGC-connected oil tankers in response to the latter's fire on its warships. Steve Witkoff and Jared Kushner meet Russian president Vladimir Putin in Moscow to deliver a proposal to end the war in Ukraine. In college football, ESPN College GameDay announces the inaugural "Hall of Fan" award, with the Ol’ Crimson flag from the Washington State Cougars as its first inductee.

=== Bossa and Vertigo === By September 2017, Faliszek had joined London-based Bossa Studios, and led Bossa's new Seattle-based studio. He was working on an unannounced cooperative game that is "trying to do something new in the narrative space using [artificial intelligence]". In May 2018, Faliszek announced he had also joined the board of advisers for Vertigo Games, and will help support a virtual reality title they are currently developing. After about a year at Bossa, Faliszek and Bossa agreed that what Faliszek had planned was not working out, in part due to his envisioned game not being the type of product Bossa had worked on before, and Faliszek left the company early in 2019. By March 2019, he founded a new studio, Stray Bombay Company, along with Riot Games' Kimberly Voll, in essence to continue the development of the cooperative title. Faliszek had previously met Voll around 2012 while Valve was exploring the VR space, and had helped Voll get Radial Games Fantastic Contraption as a SteamVR launch title. Faliszek found Voll's focus on player interaction a key part of his idea for the cooperative game. Stray Bombay was backed financially by both Riot and Upfront Ventures. The company's first game is The Anacrusis, which was released via early access in January 2022, and fully launched December 5th, 2023. Starting around 2023, Faliszek began to post TikToks and YouTube videos about his time at Valve, experiences in the games industry, and his views on game design. He would make a video about Stop Killing Games, disagreeing with the movement.

=== Cardiac === The apelin receptor is expressed early during the embryonic development of the heart, where it regulates the migration of cell progenitors fated to differentiate into cardiomyocytes, the contractile cells of the heart. Its expression is also detected in the cardiomyocytes of the adult where apelin behaves as one of the most potent stimulator of cardiac contractility. Aged apelin knockout mice develop progressive impairment of cardiac contractility. Apelin acts as a mediator of the cardiovascular control, including for blood pressure and blood flow. It is one of the most potent stimulators of cardiac contractility yet identified, and plays a role in cardiac tissue remodeling. Apelin levels are increased in left ventricles of patients with chronic heart failure and also in patients with chronic liver disease.

Sources: en.wikipedia.org

Notes from published material

The limestone walls and towers of the Kremlin were built in 1366–1368. A distinct architectural school emerged in the late 14th century. The khan of the Golden Horde initially backed Moscow in an effort to halt the eastward expansion of the Grand Duchy of Lithuania, but he continued to meddle in Moscow's relations with other Russian princes to prevent it from becoming too strong. In 1353, the Black Death spread from northwestern Russia to Moscow, causing the deaths of ruler Simeon of Moscow, his sons, and the metropolitan. The ruling family of Moscow remained small as a result, and a new vertical pattern was defined: princely succession from father to son. During the reign of Dmitry Donskoy, the Moscow principality expanded significantly in size. In 1380, Dmitry led a united Russian army to victory over the Mongols in the Battle of Kulikovo, which increased Moscow's prestige and solidified the status of its rulers as military leaders of the nation. Following Dmitry's death in 1389, the thrones of Vladimir and Moscow were permanently united. During the reign of Vasily II, a civil war broke out after Yury of Zvenigorod challenged the succession of his nephew in 1425. Moscow switched hands numerous times; Yury's son, Dmitry Shemyaka, continued to resist until his appanage center of Galich was captured in 1450. In ecclesiastical matters, Vasily disapproved of the Council of Florence, leading him to arrest the metropolitan when he returned in 1441 for having signed it.

Not as much work has been done predicting the properties of the alkali metals beyond ununennium. Although a simple extrapolation of the periodic table (by the Aufbau principle) would put element 169, unhexennium, under ununennium, Dirac-Fock calculations predict that the next element after ununennium with alkali-metal-like properties may be element 165, unhexpentium, which is predicted to have the electron configuration [Og] 5g18 6f14 7d10 8s2 8p1/22 9s1. This element would be intermediate in properties between an alkali metal and a group 11 element, and while its physical and atomic properties would be closer to the former, its chemistry may be closer to that of the latter. Further calculations show that unhexpentium would follow the trend of increasing ionisation energy beyond caesium, having an ionisation energy comparable to that of sodium, and that it should also continue the trend of decreasing atomic radii beyond caesium, having an atomic radius comparable to that of potassium. However, the 7d electrons of unhexpentium may also be able to participate in chemical reactions along with the 9s electron, possibly allowing oxidation states beyond +1, whence the likely transition metal behaviour of unhexpentium. Due to the alkali and alkaline earth metals both being s-block elements, these predictions for the trends and properties of ununennium and unhexpentium also mostly hold quite similarly for the corresponding alkaline earth metals unbinilium (Ubn) and unhexhexium (Uhh).

=== Sweden and Norway === The sale and production of absinthe has never been prohibited in Sweden or Norway. However, the only outlet that may sell alcoholic beverages containing more than 3.5% ABV in Sweden and 4.75% ABV in Norway is the government-owned chain of liquor stores known as Systembolaget in Sweden and Vinmonopolet in Norway. Systembolaget and Vinmonopolet did not import or sell absinthe for many years after the ban in France; however, today several absinthes are available for purchase in Systembolaget stores, including Swedish made distilled absinthe. In Norway, on the other hand, one is less likely to find many absinthes since Norwegian alcohol law prohibits the sale and importation of alcoholic beverages above 60% ABV, which eliminates most absinthes.

Sources: en.wikipedia.org

Background from the literature

== Interactions == Proopiomelanocortin has been shown to interact with melanocortin 4 receptor. The endogenous agonists of melanocortin 4 receptor include α-MSH, β-MSH, γ-MSH, and ACTH. The fact that these are all cleavage products of POMC should suggest likely mechanisms of this interaction.

A topical formulation of oxymetazoline, with the developmental code name DA-020, is under development for the treatment of alopecia (hair loss). As of March 2026, it is in the preclinical research stage of development for this indication. The drug is being developed by Safety Shot.

== Further reading == Biotech firm puts off rice crop here But company says it plans to sow next year. St. Louis Post-Dispatch. April 29, 2005. Pg. A3. Biotech potato provides hepatitis vaccine. The Atlanta Journal-Constitution. February 15, 2005. Pg. 3A. Biotechnology Venture Hits Unexpected Snags. The New York Times. November 23, 2001. Pg. 5. Canadian scientists make insulin from plants: 'Bio-pharming' poised to meet huge diabetes demand at less cost. The Ottawa Citizen. February 27, 2005. Pg. A1. GM corn set to stop man spreading his seed. The Observer. September 9, 2001. Pg. 1. Pharming plans transgenic first. Financial Times. May 3, 2005. Pg. 18. USDA says bio-crop safeguards are tighter ProdiGene is back in Nebraska with test plot. Omaha World Herald. June 2, 2004 Pg. 01D Release Permits for Pharmaceuticals, Industrials, Value Added Proteins for Human Consumption, or for Phytoremediation Granted or Pending by APHIS as of March 29, 2006. [2]

Sources: en.wikipedia.org

Frequently asked questions